Stephanie Lovell - May 25, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Director
Signature: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: May 25, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/30/2023, 04:30 PM
Previous filing: Nov 23, 2022
Next filing: May 28, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+1.19K		$0.00	1.19K	May 25, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+1.92K		$0.00	1.92K	May 25, 2023	Common Stock	1.92K	$71.33	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests in full on the earlier of May 25, 2024 or the date of the 2024 annual meeting of the stockholders of the Issuer, subject to continued service.